REQUEST A DEMO
Total
USD $0.00
Search more companies

4Upharma D.O.O. (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: 4Upharma D.O.O. Profile Updated: September 30, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

4Upharma D.O.O. is an enterprise in Serbia, with the main office in Belgrade. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on June 07, 2013. 4Upharma D.O.O. currently employs 20 (2024) people. There was a net sales revenue drop of 6.95% reported in 4Upharma D.O.O.’s latest financial highlights for 2024. During that time, 4Upharma D.O.O.’s total assets grew by 6.04%. In, 2024, the company’s net profit margin increased by 2.48%.

Headquarters
Maglajska 24
Belgrade; Belgrade;

Contact Details: Purchase the 4Upharma D.O.O. report to view the information.

Website: http://www.4upharma.com

Basic Information
Total Employees:
Purchase the 4Upharma D.O.O. report to view the information.
Registered Capital:
Purchase the 4Upharma D.O.O. report to view the information.
Financial Auditors:
Purchase the 4Upharma D.O.O. report to view the information.
Incorporation Date:
June 07, 2013
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Ma Real Estate
100%
Company Performance
Financial values in the chart are available after 4Upharma D.O.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
-6.95%
Total operating revenue
-6.79%
Operating profit (EBIT)
39.22%
EBITDA
31.71%
Net Profit (Loss) for the Period
20.77%
Total Assets
6.04%
Total Equity
11.87%
Operating Profit Margin (ROS)
4%
Net Profit Margin
2.48%
Return on Equity (ROE)
0.79%
Debt/Equity
-0.39%
Quick Ratio
0.19%
Cash Ratio
-0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?